Altman Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-15,461
| Closed | -$1.67M | – | 93 |
|
|
2019
Q4 | $1.67M | Sell |
15,461
-166
| -1% | -$18K | 1.34% | 45 |
|
|
2019
Q3 | $1.53M | Buy |
15,627
+1,873
| +14% | +$184K | 1.3% | 48 |
|
|
2019
Q2 | $1.8M | Buy |
13,754
+203
| +1% | +$26.6K | 1.51% | 42 |
|
|
2019
Q1 | $1.83M | Buy |
13,551
+2,277
| +20% | +$308K | 1.69% | 35 |
|
|
2018
Q4 | $1.1M | Sell |
11,274
-3,305
| -23% | -$322K | 1.2% | 43 |
|
|
2018
Q3 | $2.03M | Buy |
+14,579
| New | +$2.03M | 1.82% | 31 |
|
|
2018
Q2 | – | Sell |
-14,368
| Closed | -$1.6M | – | 103 |
|
|
2018
Q1 | $1.6M | Buy |
14,368
+999
| +7% | +$111K | 1.53% | 39 |
|
|
2017
Q4 | $1.6M | Buy |
+13,369
| New | +$1.6M | 1.39% | 39 |
|